Precision medicine for HIV: where are we?

Jessica Cusato1, Sarah Allegra1, Amedeo De Nicolò1

  • 1Department of Medical Sciences; University of Turin - ASL 'Città di Torino' Laboratory of Clinical Pharmacology and Pharmacogenetics; Amedeo di Savoia Hospital, Turin, Italy.

Pharmacogenomics
|December 6, 2017
PubMed
Summary

Personalizing antiretroviral therapy for HIV patients improves long-term efficacy and reduces adverse events. Tailored treatment plans, considering individual factors, are key for better HIV/AIDS management.